article thumbnail

San Diego's Seismic Snags $100M, Joins Unicorns

socalTECH

San Diego-based Seismic , a developer of sales and marketing software, has raised $100M more in a funding round, which values the company at $1 billion, the company said on Tuesday. Rowe Price, plus General Atlantic, JMI Equity, and Jackson Square Ventures. The funding round came from Lightspeed Venture Partners, T.

San Diego 113
article thumbnail

Evofem Prices $50M Offering

socalTECH

San Diego-based Evofem Biosciences, which is developing biopharmaceuticals for women's contraception and related areas, says it has priced a $50M, public offering, and also will receive up to an additoinal $50M upon exercise of accompanying short-term warrant.

Pricing 113
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

TuSimple Prices IPO, Starts Trading Today

socalTECH

San Diego-based TuSimple priced its IPO last night, saying that it will sell 33,783,783 shares of its Class A common stock at the price of $40.00 per share, raising just over $1 billion for the company. The company will begin trading this morning on the Nasdaq Global Select Market as TSP.

Pricing 113
article thumbnail

Event Announcement: Xcelerating Life Sciences San Diego

Xconomy

Grab yours today before prices go up. Each half-day Xcelerating Life Sciences forum is dedicated to helping industry leaders develop meaningful partnerships and explore bold new ideas to overcome healthcare’s biggest challenges. Can’t make the San Diego. Early bird tickets are on sale now for only $99.

article thumbnail

Otonomy Sets Estimated IPO Pricing Range

socalTECH

San Diego-based Otonomy , which is developing treatments for diseases of the inner and middle ear, set its estimated IPO pricing range Friday. otonomy biopharmaceuticals biotech lifescience merger acquisition inner disease exit otic pricing' and $16.00 Otonomy filed for its IPO on July 14th. READ MORE>>.

Pricing 147
article thumbnail

San Diego Life Sciences Roundup: Evofem, Cullgen, BrainLeap & More

Xconomy

Get the details on these developments and more in San Diego life sciences news: —Evofem Biosciences (NASDAQ: EVFM ) struck a deal to raise up to $80 million in a private placement. percent premium, or about $1 more per share than the previous day’s closing price, for about 6.6 million shares. million shares.

article thumbnail

Ignyta Prices IPO

socalTECH

San Diego-based precision medicine developer Ignyta has priced its IPO, saying last night that it is offering up 5,245,000 shares of its common stock at $9.15 The IPO will raised $48.0M for the company. Ignyta will trade on the NASDAQ Capital Market as RXDX, starting today.

Pricing 138